.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 4,188,390

« Back to Dashboard

Claims for Patent: 4,188,390

Title: Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
Abstract:Compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R represents 6,7-di(lower alkoxy) or 6,7,8-tri(lower alkoxy); m is 1 or 2, X is --CHR.sup.1 -- or --CH.sub.2 CH.sub.2 --; each R.sup.1 and R.sup.0 may be the same or different and is hydrogen or lower alkyl; each of R.sup.2 and R.sup.3 is hydrogen, lower alkoxy, lower alkyl, halogen, lower alkanoyl, lower alkoxycarbonyl, --CONR.sup.4 R.sup.5 or --SO.sub.2 NR.sup.4 R.sup.5 wherein each of R.sup.4 and R.sup.5 is hydrogen or lower alkyl; processes for their preparation; and their use as regulators of the cardiovascular system, and particularly in the treatment of hypertension.
Inventor(s): Campbell; Simon F. (Deal, GB2)
Assignee: Pfizer Inc. (New York, NY)
Application Number:05/952,317
Patent Claims: 1. A compound of the formula ##STR38## wherein (R).sub.n is selected from the group consisting of 6,7-di(lower alkoxy) or 6,7,8-tri(lower alkoxy);

m is 1 or 2;

X is selected from the group consisting of --CHR.sup.1 -- or --CH.sub.2 CH.sub.2 --;

each of R.sup.1 and R.sup.0 is selected from the group consisting of hydrogen or lower alkyl;

and R.sup.2 and R.sup.3, which may the same or different, are selected from the group consisting of hydrogen, lower alkyl, lower alkoxy, halogen, lower alkanoyl, lower alkoxycarbonyl or a group of the formula --CONR.sup.4 R.sup.5 or --SO.sub.2 NR.sup.4 R.sup.5 wherein R.sup.4 and R.sup.5, which may the same or different, are selected from the group consisting of hydrogen or lower alkyl; and the pharmaceutically acceptable acid addition salts thereof.

2. A compound according to claim 1 wherein each of R.sup.0 and R.sup.1 is independently H or CH.sub.3 ; and R.sup.2 and R.sup.3 are each independently hydrogen, lower alkyl, lower alkoxy, halogen, lower alkanoyl, lower alkoxycarbonyl, --CONH.sub.2 or --SO.sub.2 N(CH.sub.3).sub.2.

3. A compound according to claim 2 wherein R.sup.1 is H or CH.sub.3 ;

each of R.sup.2 and R.sup.3 is hydrogen, lower alkyl, lower alkoxy, halogen or lower alkanoyl; (R).sub.n is 6,7-dimethoxy and the pharmaceutically acceptable acid addition salts thereof; said compound having the formula ##STR39##

4. 4-Amino-2-[4-(1,4-benzodioxan-2-carbonyl)piperazin-1-yl]-6,7,8-trimethox y quinazoline, the compound according to claim 2 wherein R.sub.n is 6,7,8-trimethoxy and each of R.sup.0, R.sup.1, R.sup.2 and R.sup.3 is hydrogen.

5. 4-Amino -2-[4-(1,4-benzodioxan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazoline, the compound according to claim 3 wherein each of R.sup.1, R.sup.2 and R.sup.3 is hydrogen.

6. A pharmaceutical composition comprising a cardiovascular regulating amount of a compound according to claim 1 or a pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable diluent or carrier.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc